Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

275
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
275
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanism of Ultra-Low-Speed Smoothness in Ultrasonic Motors Based on a Macro-Micro Multi-Scale Finite Element Model.

Micromachines·2026
Same author

A study on risk prediction of decline in self-care ability one month after discharge in postoperative colorectal cancer patients based on routine clinical indicators.

Frontiers in surgery·2026
Same author

Corrections to "Reprogramming Tumor-Associated Macrophages To Reverse EGFR<sup>T790M</sup> Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat".

Nano letters·2026
Same author

Interplay of microplastics and bioturbation on atrazine dynamics in aquaculture sediments.

Journal of hazardous materials·2026
Same author

Online health information seeking, healthcare utilization, and exercise-related self-management among patients with long-term conditions in China during COVID-19.

Digital health·2026
Same author

Alexithymia and ill-being and well-being: The role of emotion regulation.

Emotion (Washington, D.C.)·2026
Same journal

Feasibility of uniportal thoracoscopic sublobar resection without chest tube drainage: a retrospective cohort study.

Frontiers in oncology·2026
Same journal

Real-world effectiveness and safety of carfilzomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma: a retrospective analysis from China.

Frontiers in oncology·2026
Same journal

Caregiver satisfaction with early integrated palliative care in oncology: secondary outcomes from the PALLiON cluster-RCT.

Frontiers in oncology·2026
Same journal

Intracranial mesenchymal tumor with FET::CREB fusion: a rare case report.

Frontiers in oncology·2026
Same journal

The multifaceted roles of mitochondria and their therapeutic transformation: a new perspective on triple-negative breast cancer treatment.

Frontiers in oncology·2026
Same journal

Trastuzumab emtansine versus trastuzumab plus pertuzumab for HER2-positive breast cancer with residual disease after neoadjuvant therapy: a real-world study.

Frontiers in oncology·2026
See all related articles

Related Experiment Video

Updated: May 23, 2025

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
07:53

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

1.3K

Data augmented lung cancer prediction framework using the nested case control NLST cohort.

Yifan Jiang1,2, Venkata S K Manem1,2,3

  • 1Centre de Recherche du CHU de Québec, Université Laval, Québec, QC, Canada.

Frontiers in Oncology
|March 12, 2025
PubMed
Summary
This summary is machine-generated.

Data augmentation significantly impacts lung cancer prediction models, with Cutmix and simple augmentation showing notable performance gains. Careful selection of augmentation methods is crucial for clinical integration of AI tools in lung cancer screening.

Keywords:
Artificial Intelliegncecancer risk predictioncomputed tomographydata augmentationlung cancermachine learning

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.6K
Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

1.7K

Related Experiment Videos

Last Updated: May 23, 2025

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
07:53

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

1.3K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.6K
Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

1.7K

Area of Science:

  • Artificial Intelligence
  • Medical Imaging
  • Oncology

Background:

  • Supervised learning for lung cancer screening is hindered by limited labeled medical images.
  • Data augmentation is a promising technique to address data scarcity in medical AI.
  • The application of data augmentation in lung cancer screening requires further investigation.

Purpose of the Study:

  • To analyze state-of-the-art data augmentation techniques for lung cancer binary prediction.
  • To evaluate the efficiency of various data augmentation methods in the context of lung cancer screening.
  • To identify optimal data augmentation strategies for deep learning models used in lung cancer detection.

Main Methods:

  • Utilized the National Lung Screening Trial (NLST) cohort (253 participants) with non-contrast CT scans.
  • Processed CT scans into 3D volumes and applied five basic (online) and two generative (offline) data augmentation methods.
  • Evaluated ten state-of-the-art (SOTA) 3D deep learning models for lung cancer prediction.

Main Results:

  • Performance improvement varied significantly based on the augmentation approach.
  • Cutmix yielded the highest average performance gains: 1.07% accuracy, 3.29% F1 score, and 1.19% AUC.
  • MobileNetV2 with simple augmentation achieved the best AUC (0.8719), a 7.62% improvement; MED-DDPM rebalanced data and improved predictions.

Conclusions:

  • Data augmentation effectiveness is highly model-dependent, emphasizing the need for careful method selection.
  • Traditional augmentation methods can outperform SOTA online approaches in stability and performance.
  • Findings provide insights for developing and integrating data-augmented deep learning tools for lung cancer screening.